Related Experiment Video

Updated: Oct 7, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism

N S Shachter1

  • 1Divisions of Preventive Medicine and Nutrition, and Cardiology, Columbia University, New York, New York 10032-3702, USA. nss5@columbia.edu

Current Opinion in Lipidology
|May 16, 2001
PubMed

Insights

Apolipoprotein C-I and C-III (apoC-I, apoC-III) hinder the clearance of triglyceride-rich lipoproteins. Their varying expression impacts hypertriglyceridemia, influencing lipid metabolism and cardiovascular health.

Area of Science:

  • Lipid Metabolism
  • Cardiovascular Science
  • Biochemistry

Background:

  • Apolipoprotein C-I (apoC-I) and apolipoprotein C-III (apoC-III) are key components of high-density lipoproteins (HDL) and triglyceride-rich lipoproteins (TRLs).
  • These apolipoproteins play critical roles in regulating lipoprotein metabolism and clearance.
  • Dysregulation of apoC-I and apoC-III expression is implicated in lipid disorders.

Purpose of the Study:

  • To elucidate the mechanisms by which apoC-I and apoC-III influence the clearance of triglyceride-rich lipoproteins.
  • To explore the roles of apoC-I and apoC-III in the pathogenesis of hypertriglyceridemia.
  • To understand how variations in apoC-I and apoC-III expression affect lipoprotein metabolism.

Main Methods:

  • Investigated the inhibitory effects of apoC-I on lipoprotein binding to LDL receptor, LDL receptor-related protein, and VLDL receptor.
  • Examined the role of apoC-I as a plasma inhibitor of cholesteryl ester transfer protein (CETP) and its effect on fatty acid uptake.
  • Analyzed the inhibitory mechanisms of apoC-III on lipolysis, including lipoprotein lipase (LPL) activity and binding to cell-surface glycosaminoglycans.

Main Results:

  • ApoC-I inhibits lipoprotein clearance by interfering with receptor binding and CETP activity, and potentially direct fatty acid uptake.
  • ApoC-III primarily acts as an inhibitor of lipolysis by biochemically inhibiting LPL and disrupting lipoprotein binding to cell-surface proteoglycans.
  • Variations in apoC-III expression are strongly linked to hypertriglyceridemia; apoC-I expression variations may also contribute under specific conditions.

Conclusions:

  • ApoC-I and apoC-III are significant regulators of triglyceride-rich lipoprotein metabolism and clearance.
  • Their distinct mechanisms of action contribute to the development of hypertriglyceridemia.
  • Understanding these apolipoproteins' roles is crucial for developing therapeutic strategies for dyslipidemia.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion06:14

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion

Published on: November 30, 2022

Related Concept Videos

Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...